FDA Approved: GABARONE — Supplemental Application (INA Pharmaceutics Inc.)

View source ↗

Summary

FDA approved a supplemental application for GABARONE (gabapentin) by INA Pharmaceutics Inc. under ANDA211313. This action typically reflects changes to formulat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Postherpetic Neuralgia

Drugs mentioned

• GABARONE (GABAPENTIN)

Snippet

SUPPL AP for GABARONE (GABAPENTIN)